CoChat

The DOI matches its Crossref record.

Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein

Packard, C.J. · 2003 · Biochemical Society Transactions

Abstract

LDL (low-density lipoprotein) is the major carrier of cholesterol in human plasma, and as such is intimately involved in the process of atherosclerosis. The lipoprotein class comprises a number of distinct subfractions, and is commonly divided into large, intermediate and small sized particles. Small, dense LDLs are held to be particularly atherogenic, since these particles are retained preferentially by the artery wall, are readily oxidized and carry an enzyme believed to have an important role in atherosclerosis, i.e. lipoprotein-associated phospholipase A2. Generation of small, dense LDL occurs by intravascular lipoprotein remodelling as a result of disturbances such as Type II diabetes, metabolic syndrome, renal disease and pre-eclampsia. The key predisposing factor is the development of hypertriglyceridaemia, in particular elevation in the plasma concentration of large, triacylglycerol-rich VLDL (very-low-density lipoprotein). This leads to the formation of slowly metabolized LDL particles (5-day residence time), which are subject to exchange processes that remove cholesteryl ester from the particle core and replace it with triacylglycerol. LDL, so altered, is a potential substrate for hepatic lipase; if the activity of the enzyme is high enough, lipolysis will generate smaller, denser particles. Correction of the dyslipidaemia associated with small, dense LDL is possible using fibrates and statins, and this may contribute to the clinical benefits seen with these drugs. Fibrates act to lower plasma triacylglycerol (VLDL) levels, and so correct the underlying metabolic disturbance. Statins remove VLDL particles via receptor-mediated pathways and reduce the residence time (and hence limit the potential for remodelling) of LDL in the circulation.

Overview

Integrity signals

Registry

Crossref · 10.1042/bst0311066

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 227

Metadata

Authors
Packard, C. J.
Affiliations
Glasgow Royal Infirmary (GB)
Corresponding author
Packard, C.J.
Venue
Biochemical Society Transactions
Published
2003-10-01
Volume
31
Issue
5
Pages
1066-1069
ISSN
  • 0300-5127 (ISSN-L)
  • 1470-8752
OpenAlex
W2121209370
Cited by
225
References
0
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 7 · 2022: 3 · 2021: 13 · 2020: 12 · 2019: 6 · 2018: 7 · 2017: 12 · 2016: 9 · 2015: 15 · 2014: 13 · 2013: 10 · 2012: 11
FWCI
9.91
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical Society Transactions (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
small dense LDL, triglyceride-rich lipoproteins, VLDL, hypertriglyceridemia, hepatic lipase, lipolysis, atherosclerosis, lipoprotein-associated phospholipase A2, fibrates, statins, dyslipidemia, cholesterol esters
MeSH terms
Animals, Diabetes Mellitus, Humans, Lipoproteins, Lipoproteins, LDL, Models, Biological, Phospholipases A, Triglycerides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. https://app.cochat.ai/papers/10.1042/bst0311066
The paper
Packard, C. J. (2003). Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochemical Society Transactions. https://doi.org/10.1042/bst0311066

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.